Holdings Channel
Home Articles Latest Filings All Funds Stocks Being Bought Stocks Being Sold Insider Buying
Play Video: The Importance of Insider Buying


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
NHI — Current Quote
Quotes delayed 20 minutes

Email EnvelopeFree NHI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

NHI — Performance
More Insider Buying
Other companies seeing insider buying close in time to when the National Health Investors Insider Buying occurred are:

LCNB Insider Buying
WesBanco Insider Buying
First Community Corp (SC) Insider Buying
AVITA Medical Insider Buying
Assured Guaranty Insider Buying
Ondas Holdings Insider Buying
Zions Bancorporation N.A. Insider Buying
Enphase Energy Insider Buying
Western Union Insider Buying
South Plains Financial Insider Buying

National Health Investors insider buying image
The table below summarizes the most recent National Health Investors insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why National Health Investors insider buys are important for investors to follow.
DateInsiderPriceAmount
2-27-2024
Insider Buy		 Charlotte A. Swafford
Director		 $58.69
CAGR » 		$586,882.00
10,000 shares
8-30-2023
Insider Buy		 James R. Jobe
Director		 $51.40
CAGR » 		$51,398.20
1,000 shares
12-14-2022
Insider Buy		 Robert G. Adams
Director		 $56.60
CAGR » 		$56,600.00
1,000 shares
8-15-2022
Insider Buy		 Robert G. Adams
Director		 $65.93
CAGR » 		$98,895.00
1,500 shares
12-30-2021
Insider Buy		 Robert G. Adams
Director		 $57.25
CAGR » 		$114,500.00
2,000 shares
12-1-2021
Insider Buy		 Robert T. Webb
Director		 $52.02
CAGR » 		$156,060.00
3,000 shares
9-29-2021
Insider Buy		 D. Eric Mendelsohn
CEO and President		 $54.38
CAGR » 		$108,756.68
2,000 shares
9-30-2021
Insider Buy		 Robert T. Webb
Director		 $53.86
CAGR » 		$107,715.00
2,000 shares
9-17-2021
Insider Buy		 Robert T. Webb
Director		 $57.38
CAGR » 		$172,125.00
3,000 shares
9-14-2021
Insider Buy		 Robert T. Webb
Director		 $58.00
CAGR » 		$87,000.00
1,500 shares
9-10-2021
Insider Buy		 Robert T. Webb
Director		 $58.50
CAGR » 		$87,750.00
1,500 shares
9-9-2021
Insider Buy		 Robert A. McCabe Jr.
Director		 $59.84
CAGR » 		$28,002.78
468 shares
6-17-2021
Insider Buy		 Robert T. Webb
Director		 $65.00
CAGR » 		$76,960.00
1,184 shares
12-14-2020
Insider Buy		 Robert G. Adams
Director		 $67.75
CAGR » 		$135,500.00
2,000 shares
11-18-2020
Insider Buy		 Robert G. Adams
Director		 $66.35
CAGR » 		$331,769.60
5,000 shares
5-13-2020
Insider Buy		 Robert G. Adams
Director		 $48.36
CAGR » 		$20,553.00
425 shares
3-23-2020
Insider Buy		 W. Andrew Adams
Director		 $36.16
CAGR » 		$976,320.00
27,000 shares
5-25-2018
Insider Buy		 Robert A. McCabe Jr.
Director		 $72.00
CAGR » 		$20,520.00
285 shares
2-26-2018
Insider Buy		 Robert A. McCabe Jr.
Director		 $65.69
CAGR » 		$20,495.28
312 shares
11-29-2017
Insider Buy		 Robert A. McCabe Jr.
Director		 $78.23
CAGR » 		$20,574.02
263 shares
8-28-2017
Insider Buy		 Robert A. McCabe Jr.
Director		 $79.94
CAGR » 		$20,704.46
259 shares
12-11-2015
Insider Buy		 Robert A. McCabe Jr.
Director		 $59.10
CAGR » 		$2,068.50
35 shares
11-27-2015
Insider Buy		 Robert A. McCabe Jr.
Director		 $60.34
CAGR » 		$7,844.20
130 shares
11-17-2015
Insider Buy		 D. Eric Mendelsohn
CEO and President		 $56.12
CAGR » 		$56,120.00
1,000 shares
8-31-2015
Insider Buy		 Robert A. McCabe Jr.
Director		 $56.21
CAGR » 		$17,425.10
310 shares
8-25-2015
Insider Buy		 Robert T. Webb
Director		 $56.75
CAGR » 		$283,749.50
5,000 shares
8-26-2015
Insider Buy		 D. Eric Mendelsohn
Interim CEO and President		 $55.38
CAGR » 		$41,537.78
750 shares
8-25-2015
Insider Buy		 James R. Jobe
Director		 $56.68
CAGR » 		$5,668.00
100 shares
8-24-2015
Insider Buy		 D. Eric Mendelsohn
Interim CEO and President		 $56.99
CAGR » 		$42,742.50
750 shares
8-13-2015
Insider Buy		 James R. Jobe
Director		 $58.71
CAGR » 		$5,871.00
100 shares
8-13-2015
Insider Buy		 Kevin Carlton Pascoe
EVP - Investments		 $58.61
CAGR » 		$29,305.00
500 shares
8-13-2015
Insider Buy		 Roger R. Hopkins
Chief Accounting Officer		 $58.61
CAGR » 		$87,915.00
1,500 shares
8-13-2015
Insider Buy		 D. Eric Mendelsohn
Interim CEO and President		 $58.80
CAGR » 		$88,200.00
1,500 shares
8-13-2015
Insider Buy		 Roger R. Hopkins
Chief Accounting Officer		 $58.61
CAGR » 		$87,915.00
1,500 shares
8-13-2015
Insider Buy		 D. Eric Mendelsohn
Interim CEO and President		 $58.80
CAGR » 		$88,200.00
1,500 shares
8-13-2015
Insider Buy		 James R. Jobe
Director		 $58.71
CAGR » 		$5,871.00
100 shares
6-9-2015
Insider Buy		 D. Eric Mendelsohn
EVP - Corporate Finance		 $63.80
CAGR » 		$31,900.00
500 shares
5-29-2015
Insider Buy		 Robert A. McCabe Jr.
Director		 $66.99
CAGR » 		$17,752.32
265 shares
5-14-2015
Insider Buy		 James R. Jobe
Director		 $66.37
CAGR » 		$13,273.98
200 shares
5-13-2015
Insider Buy		 D. Eric Mendelsohn
EVP - Corporate Finance		 $65.77
CAGR » 		$98,656.85
1,500 shares
2-27-2015
Insider Buy		 Robert A. McCabe Jr.
Director		 $71.17
CAGR » 		$28,327.25
398 shares
9-23-2014
Insider Buy		 Robert A. McCabe Jr.
Director		 $59.23
CAGR » 		$12,142.13
205 shares
8-29-2014
Insider Buy		 Robert A. McCabe Jr.
Director		 $64.41
CAGR » 		$11,593.78
180 shares
8-6-2014
Insider Buy		 Roger R. Hopkins
Chief Accounting Officer		 $61.43
CAGR » 		$52,215.50
850 shares
8-6-2014
Insider Buy		 James Justin Hutchens
CEO and President		 $61.40
CAGR » 		$125,256.00
2,040 shares
6-24-2014
Insider Buy		 James R. Jobe
Director		 $63.47
CAGR » 		$63,470.00
1,000 shares
6-2-2014
Insider Buy		 Robert A. McCabe Jr.
Director		 $62.85
CAGR » 		$12,569.98
200 shares
5-13-2014
Insider Buy		 James R. Jobe
Director		 $61.79
CAGR » 		$55,608.00
900 shares
2-28-2014
Insider Buy		 Robert A. McCabe Jr.
Director		 $61.72
CAGR » 		$11,726.51
190 shares
9-10-2013
Insider Buy		 James Justin Hutchens
CEO and President		 $54.77
CAGR » 		$27,385.00
500 shares
9-9-2013
Insider Buy		 Robert A. McCabe Jr.
Director		 $54.47
CAGR » 		$44,936.93
825 shares
6-3-2013
Insider Buy		 James Justin Hutchens
CEO and President		 $62.23
CAGR » 		$100,185.15
1,610 shares
5-31-2013
Insider Buy		 James R. Jobe
Director		 $63.85
CAGR » 		$6,385.00
100 shares

Also See: Institutional Holders of NHI
Also See: SEC filings

NHI Performance Since Insider Purchase
Below we present the annualized performance delivered by National Health Investors stock since 2-27-2024 (the date of the most recent insider purchase). The performance of the investment from the time National Health Investors insider buying occurred is the ultimate test of whether insiders were right about NHI being a good buy.

Growth of $10,000.00
With Dividends Reinvested
Start date: 02/28/2024
End date: 04/26/2024
Start price/share: $58.48
End price/share: $62.89
Starting shares: 171.00
Ending shares: 173.49
Dividends reinvested/share: $0.90
Total return: 9.11%
Annualized Gain: 58.31%
Starting investment: $10,000.00
Ending investment: $10,911.00
Years: 0.16
 
Growth of $10,000.00
Without Dividends Reinvested
Start date: 02/28/2024
End date: 04/26/2024
Start price/share: $58.48
End price/share: $62.89
Dividends collected/share: $0.90
Total return: 9.08%
Annualized Gain: 58.14%
Starting investment: $10,000.00
Ending investment: $10,908.00
Years: 0.16

National Health Investors Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent National Health Investors insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding NHI

National Health Investors Insider Buying | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.